Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination treatment of RAS-positive diseases with PDE-δ inhibitor and direct autophagy inhibitor

Combination treatment of RAS-positive diseases with PDE-δ inhibitor and direct autophagy inhibitor

US Patent 9861623 · Granted Jan 9, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dual-target fusion proteins comprising FGF21 and GLP-1, connected through a Fc p2024
Targeted CD73 antibody and antibody-drug conjugate, and preparation method there2024
Medicinal composition comprising a non-coding RNA molecule and an antibody targe2024
FGF21 variant, fusion protein and application thereof2023
Hydrogel platform for aqueous two-phase concentration of a target to enhance its2022
Use of glycan as biomarkers for autoimmune diseases2021
Method of identifying a gene associated with a disease or pathological condition2020
Method of identifying a gene associated with a disease or pathological condition2020
Methods of treating cancer2020
Methods of treating cancer2020
Method of treating refractory rheumatoid arthritis associated with p53 mutation2020
Triterpenoid obtainable from hedera helix for treatment of neurodegenerative dis2019